VitriVax

About:

VitriVax is a biotech startup that develops a vaccine formulation platform.

Top Investors: Bill & Melinda Gates Foundation, Adjuvant Capital

Description:

VitriVax is a biotech startup that develops a vaccine formulation platform. VitriVax's proprietary technology, created at the University of Colorado with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally. VitriVax is headquartered in Boulder, Colorado.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)vitrivaxbio.com

Founders:

Robert Garcea, Theodore Randolph

Number of Employees:

11-50

Last Funding Date:

2023-12-06

IPO Status:

Private

Industries: